Zoller W G, Wagner D R, Zentner J
Medizinische Poliklinik, Ludwig-Maximilians-Universität München.
Clin Investig. 1993 Aug;71(8):654-8. doi: 10.1007/BF00184496.
In the past decade several randomized trials have shown a beneficial effect of propranolol in cirrhotic patients. The effect of propranolol has been attributed to a reduction in portal vein pressure. So far the monitoring of portal vein hemodynamics following propranolol administration has been achieved mainly by hepatic vein catheterization. We studied the effect of propranolol on portal vein hemodynamics noninvasively in five healthy volunteers using duplex sonography and indocyanine green clearance. Measured by duplex sonography, blood flow was reduced by 28.6% in the portal vein (P < 0.05) and by 8.7% in the hepatic artery (NS) 60 min after oral administration of 80 mg propranolol. During this time total hepatic blood flow, measured by indocyanine green clearance, was reduced by 19.5% (P < 0.05). We conclude that both methods are useful for the study of portal vein hemodynamics during propranolol therapy, duplex sonography being more easily practicable.
在过去十年中,多项随机试验表明普萘洛尔对肝硬化患者有有益作用。普萘洛尔的作用归因于门静脉压力的降低。到目前为止,普萘洛尔给药后门静脉血流动力学的监测主要通过肝静脉插管来实现。我们使用双功超声和吲哚菁绿清除率对5名健康志愿者进行了无创研究,以观察普萘洛尔对门静脉血流动力学的影响。口服80毫克普萘洛尔60分钟后,通过双功超声测量,门静脉血流减少了28.6%(P<0.05),肝动脉血流减少了8.7%(无统计学意义)。在此期间,通过吲哚菁绿清除率测量的肝脏总血流量减少了19.5%(P<0.05)。我们得出结论,这两种方法都有助于研究普萘洛尔治疗期间的门静脉血流动力学,双功超声更易于实施。